HK1206987A1 - 放射線損害的預防和/或治療劑 - Google Patents

放射線損害的預防和/或治療劑

Info

Publication number
HK1206987A1
HK1206987A1 HK15107650.9A HK15107650A HK1206987A1 HK 1206987 A1 HK1206987 A1 HK 1206987A1 HK 15107650 A HK15107650 A HK 15107650A HK 1206987 A1 HK1206987 A1 HK 1206987A1
Authority
HK
Hong Kong
Prior art keywords
prophylactic
therapeutic agent
radiation damage
radiation
damage
Prior art date
Application number
HK15107650.9A
Other languages
English (en)
Inventor
田中徹
中島元夫
安部史紀
伊東秀典
高橋究
松島綱治
上羽悟史
阿部淳
Original Assignee
Univ Tokyo
Sbi Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Tokyo, Sbi Pharmaceuticals Co Ltd filed Critical Univ Tokyo
Publication of HK1206987A1 publication Critical patent/HK1206987A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
HK15107650.9A 2012-07-23 2015-08-08 放射線損害的預防和/或治療劑 HK1206987A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012163110 2012-07-23
PCT/JP2013/004292 WO2014017046A1 (ja) 2012-07-23 2013-07-11 放射線障害の予防及び／又は治療剤

Publications (1)

Publication Number Publication Date
HK1206987A1 true HK1206987A1 (zh) 2016-01-22

Family

ID=49996874

Family Applications (2)

Application Number Title Priority Date Filing Date
HK15106310.3A HK1205687A1 (zh) 2012-07-23 2015-07-02 輻射損害的預防和/或治療劑
HK15107650.9A HK1206987A1 (zh) 2012-07-23 2015-08-08 放射線損害的預防和/或治療劑

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK15106310.3A HK1205687A1 (zh) 2012-07-23 2015-07-02 輻射損害的預防和/或治療劑

Country Status (7)

Country Link
US (1) US9895331B2 (zh)
EP (1) EP2875812B1 (zh)
JP (1) JP5920902B2 (zh)
CN (1) CN104487066B (zh)
HK (2) HK1205687A1 (zh)
TW (1) TWI637743B (zh)
WO (1) WO2014017046A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2670413T3 (es) 2003-06-03 2018-05-30 The United States Government As Represented By The Department Of Health And Human Services Suplementos nutricionales y composiciones terapéuticas que comprenden derivados de (R)-3-hidroxibutirato
US8642654B2 (en) 2009-04-16 2014-02-04 Isis Innovation Limited Hydroxybutyrate ester and medical use thereof
AU2013337308B2 (en) 2012-11-05 2018-06-21 Tdeltas Ketone bodies to protect tissues from damage by ionizing radiation
GB201304467D0 (en) 2013-03-12 2013-04-24 Tdeltas Ltd Compound for use in protecting skin
BR112015023334B1 (pt) 2013-03-14 2021-05-18 Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services processo para produção de (r)-3hidroxibutil (r)-3-hidroxibutirato
WO2018124067A1 (ja) 2016-12-27 2018-07-05 ＭｉＺ株式会社 放射線障害防御剤
CN111060697A (zh) * 2019-02-24 2020-04-24 中国疾病预防控制中心辐射防护与核安全医学所 一种利用hmgb1的小肠放射性损伤标记方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079262A (en) * 1989-07-28 1992-01-07 Queen's University At Kingston Method of detection and treatment of malignant and non-malignant lesions utilizing 5-aminolevulinic acid
JPH0539218A (ja) 1991-08-05 1993-02-19 Sanwa Kagaku Kenkyusho Co Ltd 放射線障害治療剤
JP3170364B2 (ja) 1992-11-05 2001-05-28 中外製薬株式会社 放射線障害防護剤
JPH07165602A (ja) 1993-12-16 1995-06-27 Kirin Brewery Co Ltd 放射線障害防護剤
AT407833B (de) 1995-06-01 2001-06-25 Nowicky Wassyl Dr Mittel zur behandlung von strahlenschäden
JP2003335674A (ja) 2002-03-12 2003-11-25 Mitsubishi Pharma Corp 放射線障害の予防剤および治療剤
JP2004043391A (ja) 2002-07-15 2004-02-12 Eisai Co Ltd 放射線障害軽減剤
JP2007512378A (ja) 2003-11-26 2007-05-17 アークル インコーポレイテッド 放射線障害から保護するためのβ−ラパコンの使用
JPWO2006033412A1 (ja) 2004-09-24 2008-05-15 株式会社林原生物化学研究所 放射線障害軽減剤
JP2007302640A (ja) 2006-05-15 2007-11-22 Natl Inst Of Radiological Sciences 抗放射線被ばく障害剤
CN102014890B (zh) 2008-05-14 2015-08-05 思佰益药业股份有限公司 男性不育治疗剂
JP5295652B2 (ja) * 2008-06-16 2013-09-18 Ｓｂｉファーマ株式会社 光障害の軽減剤
CN103800310A (zh) 2008-10-27 2014-05-21 思佰益药业股份有限公司 以5-氨基乙酰丙酸或其衍生物、或它们的盐作为有效成分的成人病的预防、改善剂
JP5611548B2 (ja) * 2009-07-08 2014-10-22 Ｓｂｉファーマ株式会社 ５−アミノレブリン酸若しくはその誘導体、又はそれらの塩を有効成分とするがんの予防・改善剤
JP5553306B2 (ja) 2010-03-30 2014-07-16 国立大学法人福井大学 放射線障害防護剤
EP2767279B1 (en) * 2011-10-12 2018-12-12 SBI Pharmaceuticals Co., Ltd. Erythropoietin production-promoting agent

Also Published As

Publication number Publication date
EP2875812A1 (en) 2015-05-27
JPWO2014017046A1 (ja) 2016-07-07
WO2014017046A1 (ja) 2014-01-30
TWI637743B (zh) 2018-10-11
CN104487066A (zh) 2015-04-01
HK1205687A1 (zh) 2015-12-24
TW201412307A (zh) 2014-04-01
CN104487066B (zh) 2020-06-09
US20150190356A1 (en) 2015-07-09
EP2875812A4 (en) 2016-02-24
EP2875812B1 (en) 2019-09-04
US9895331B2 (en) 2018-02-20
JP5920902B2 (ja) 2016-05-18

Similar Documents

Publication Publication Date Title
HK1214453A1 (zh) 隨機接入過程及相關裝置
IL229323B (en) Device for radiation protection and methods thereof
HK1210031A1 (zh) 癡呆症治療藥或預防藥
HK1206666A1 (zh) 光療裝置和方法
IL235536B (en) Material devices - on and methods of using them
EP2827935A4 (en) DEVICES AND METHODS FOR ENDOVASCULAR ACCESS AND THERAPY
EP2840951A4 (en) METHODS AND DEVICES FOR TISSUE RETRACTION
HK1216297A1 (zh) 腫瘤溶解綜合征的治療藥和預防藥
IL239478B (en) Preparations for the treatment or prevention of dry eye
EP2830617A4 (en) IPA AS A THERAPEUTIC AGENT, AS A PROTECTIVE AGENT AND AS A BIOMARKER FOR DISEASE RISKS
EP2537530A4 (en) RADIOTHERAPY AGENT
HK1206987A1 (zh) 放射線損害的預防和/或治療劑
EP2884984A4 (en) THERAPEUTIC COMPOSITIONS AND METHOD
IL234756A0 (en) A preparation for regulating the immune system and its uses
EP2931140A4 (en) Tissue repair equipment and methods
HK1209639A1 (zh) 的抑制及其治療用途
GB201214736D0 (en) Inflammation imaging and therapy
PL2882446T3 (pl) Terapia profilaktyczna i nutraceutyczna
EP2895186A4 (en) THERAPEUTIC COMPOSITIONS AND RELATED METHODS
EP2745838A4 (en) PROPHYLACTIC AGENT AND / OR THERAPEUTIC AGENT FOR SEPTICEMIA
HK1203159A1 (zh) 用於壓力性尿失禁的預防劑和/或治療劑
EP2817004A4 (en) BOUVARDIN DERIVATIVES AND THEIR THERAPEUTIC USES
EP2878344A4 (en) FIRE EXTINGUISHING AGENT AND FIRE EXTINGUISHING APPARATUS
EP2922165A4 (en) BATTERY PROTECTION APPARATUS AND BATTERY APPARATUS